Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors.

[1]  Stephan von Haehling,et al.  Inflammatory mediators in chronic heart failure: an overview , 2004, Heart.

[2]  S. Anker,et al.  Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications. , 2004, Basic research in cardiology.

[3]  Martin J. Lohse,et al.  What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure? , 2003, Circulation research.

[4]  S. Anker,et al.  Tumour necrosis factor-α and the failing heart , 2003, Basic Research in Cardiology.

[5]  S. Liggett,et al.  Update on current concepts of the molecular basis of beta2-adrenergic receptor signaling. , 2002, The Journal of allergy and clinical immunology.

[6]  Malcolm W Johnson.  Effects of beta2-agonists on resident and infiltrating inflammatory cells. , 2002, The Journal of allergy and clinical immunology.

[7]  S. Anker,et al.  Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. , 2002, The American journal of cardiology.

[8]  R. Schwinger,et al.  Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium , 2001, British journal of pharmacology.

[9]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[10]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[11]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[12]  S. Calvano,et al.  Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation. , 1997, American journal of physiology. Endocrinology and metabolism.

[13]  P. Poole‐Wilson,et al.  Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. , 1997, The American journal of cardiology.

[14]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[15]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[16]  Jiunn-Ren Wu,et al.  Reduction in lymphoctye β-adreneraic receptor density in infants and children with heart failure secondary to congenital heart disease , 1996 .

[17]  S. Ishida,et al.  Effect of metoprolol on the β-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathy , 1993 .

[18]  C. Hunter,et al.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. , 1992, Journal of immunology.

[19]  P. Molinoff,et al.  Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure. , 1989, The American journal of cardiology.

[20]  P. Cryer,et al.  Biphasic Adrenergic Modulation of β-Adrenergic Receptors in Man: AGONIST-INDUCED EARLY INCREMENT AND LATE DECREMENT IN β-ADRENERGIC RECEPTOR NUMBER , 1980 .